Literature DB >> 1427398

The role of laparoscopic lymphadenectomy in the management of cervical carcinoma.

J M Childers1, K Hatch, E A Surwit.   

Abstract

Laparoscopic lymphadenectomy was performed on 18 patients with invasive carcinoma of the cervix prior to definitive radiation therapy and/or radical hysterectomy. Ten patients underwent pelvic and para-aortic lymphadenectomies prior to planned radiotherapy. Two of these patients had grossly positive pelvic nodes, and one had a microscopically positive para-aortic node. Eight patients with early disease were considered candidates for radical hysterectomy and underwent laparoscopic lymphadenectomy. Three of these patients were found to have positive pelvic lymph nodes and the hysterectomy was abandoned. Five patients underwent radical hysterectomies immediately following their laparoscopic procedures. The average number of lymph nodes removed laparoscopically in these patients was 31.4; the average number of additional lymph nodes resected at laparotomy with the radical hysterectomy was 2.8. A single microscopically positive parametrial lymph node was found on permanent section in 1 patient with radical hysterectomy. No significant complications were associated with the laparoscopic lymphadenectomies. Nine of the 13 patients who underwent laparoscopic procedures only were discharged on Postoperative Day 1. The ability to perform pelvic and para-aortic lymphadenectomy allows for complete surgical staging of carcinoma of the cervix laparoscopically.

Entities:  

Mesh:

Year:  1992        PMID: 1427398     DOI: 10.1016/0090-8258(92)90072-q

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  10 in total

1.  Laparoscopically assisted radical vaginal versus radical abdominal hysterectomy type II in patients with cervical cancer.

Authors:  S Malur; M Possover; A Schneider
Journal:  Surg Endosc       Date:  2000-12-12       Impact factor: 4.584

2.  Laparoscopic splenectomy. Technique and results in a series of 27 cases.

Authors:  A Emmermann; C Zornig; M Peiper; H J Weh; C E Broelsch
Journal:  Surg Endosc       Date:  1995-08       Impact factor: 4.584

3.  Laparoscopic splenectomy and lymph node biopsy for hematologic disorders.

Authors:  M Rhodes; M Rudd; N O'Rourke; L Nathanson; G Fielding
Journal:  Ann Surg       Date:  1995-07       Impact factor: 12.969

4.  Experiences of pretreatment laparoscopic surgical staging in patients with locally advanced cervical cancer: results of a prospective study.

Authors:  Myong Cheol Lim; Jaeman Bae; Jeong-Yoel Park; Soyi Lim; Sokbom Kang; Sang-Soo Seo; Joo-Yong Kim; Ju-Won Rho; Sang-Yoon Park
Journal:  J Gynecol Oncol       Date:  2008-06-20       Impact factor: 4.401

5.  Extra-peritoneal laparoscopic para-aortic lymphadenectomy--a prospective cohort study of 293 patients with endometrial cancer.

Authors:  Sean C Dowdy; Giovanni Aletti; William A Cliby; Karl C Podratz; Andrea Mariani
Journal:  Gynecol Oncol       Date:  2008-10-02       Impact factor: 5.482

Review 6.  Operative laparoscopy: redefining the limits.

Authors:  C Nezhat; F Nezhat; C Nezhat; D S Seidman
Journal:  JSLS       Date:  1997 Jul-Sep       Impact factor: 2.172

Review 7.  Endoscopic management of adnexal masses.

Authors:  L Mettler; K Semm; K Shive
Journal:  JSLS       Date:  1997 Apr-Jun       Impact factor: 2.172

8.  Laparoscopic staging of endometrial cancer: the learning experience.

Authors:  T D Melendez; J M Childers; M Nour; K Harrigill; E A Surwit
Journal:  JSLS       Date:  1997 Jan-Mar       Impact factor: 2.172

Review 9.  Laparoscopic technique of para-aortic lymph node dissection: A comparison of the different approaches to trans- versus extraperitoneal para-aortic lymphadenectomy.

Authors:  Soshi Kusunoki; Kuan-Gen Huang; Angelito Magno; Chyi-Long Lee
Journal:  Gynecol Minim Invasive Ther       Date:  2016-02-08

10.  New Peritoneal Traction Device for Laparoscopic Paraaortic Lymphadenectomy.

Authors:  Seiji Mabuchi; Yuri Matsumoto; Sho Matsubara
Journal:  JSLS       Date:  2020 Jan-Mar       Impact factor: 2.172

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.